BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15771438)

  • 1. Comparison of sulfamate and sulfamide groups for the inhibition of carbonic anhydrase-II by using topiramate as a structural platform.
    Maryanoff BE; McComsey DF; Costanzo MJ; Hochman C; Smith-Swintosky V; Shank RP
    J Med Chem; 2005 Mar; 48(6):1941-7. PubMed ID: 15771438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue.
    Winum JY; Temperini C; El Cheikh K; Innocenti A; Vullo D; Ciattini S; Montero JL; Scozzafava A; Supuran CT
    J Med Chem; 2006 Nov; 49(24):7024-31. PubMed ID: 17125255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of carbonic anhydrase-II by sulfamate and sulfamide groups: an investigation involving direct thermodynamic binding measurements.
    Klinger AL; McComsey DF; Smith-Swintosky V; Shank RP; Maryanoff BE
    J Med Chem; 2006 Jun; 49(12):3496-500. PubMed ID: 16759092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivatives.
    Maryanoff BE; Costanzo MJ; Nortey SO; Greco MN; Shank RP; Schupsky JJ; Ortegon MP; Vaught JL
    J Med Chem; 1998 Apr; 41(8):1315-43. PubMed ID: 9548821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties.
    Masereel B; Rolin S; Abbate F; Scozzafava A; Supuran CT
    J Med Chem; 2002 Jan; 45(2):312-20. PubMed ID: 11784136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase inhibitors: SAR and X-ray crystallographic study for the interaction of sugar sulfamates/sulfamides with isozymes I, II and IV.
    Casini A; Antel J; Abbate F; Scozzafava A; David S; Waldeck H; Schäfer S; Supuran CT
    Bioorg Med Chem Lett; 2003 Mar; 13(5):841-5. PubMed ID: 12617904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of two independent kinetic assays for determining the inhibition of carbonic anhydrases I and II: structure-activity comparison of sulfamates and sulfamides.
    Shank RP; McComsey DF; Smith-Swintosky VL; Maryanoff BE
    Chem Biol Drug Des; 2006 Aug; 68(2):113-9. PubMed ID: 16999776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibition. Insight into the characteristics of zonisamide, topiramate, and the sulfamide cognate of topiramate.
    Shank RP; Smith-Swintosky VL; Maryanoff BE
    J Enzyme Inhib Med Chem; 2008 Apr; 23(2):271-6. PubMed ID: 18343915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsant 4-aminobenzenesulfonamide derivatives with branched-alkylamide moieties: X-ray crystallography and inhibition studies of human carbonic anhydrase isoforms I, II, VII, and XIV.
    Hen N; Bialer M; Yagen B; Maresca A; Aggarwal M; Robbins AH; McKenna R; Scozzafava A; Supuran CT
    J Med Chem; 2011 Jun; 54(11):3977-81. PubMed ID: 21506569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel sulfamides as potential carbonic anhydrase isoenzymes inhibitors.
    Akıncıoğlu A; Akbaba Y; Göçer H; Göksu S; Gülçin İ; Supuran CT
    Bioorg Med Chem; 2013 Mar; 21(6):1379-85. PubMed ID: 23394864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbonic anhydrase-II inhibition. what are the true enzyme-inhibitory properties of the sulfamide cognate of topiramate?
    Maryanoff BE; McComsey DF; Lee J; Smith-Swintosky VL; Wang Y; Minor LK; Todd MJ
    J Med Chem; 2008 Apr; 51(8):2518-21. PubMed ID: 18363349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promiscuity of carbonic anhydrase II. Unexpected ester hydrolysis of carbohydrate-based sulfamate inhibitors.
    Lopez M; Vu H; Wang CK; Wolf MG; Groenhof G; Innocenti A; Supuran CT; Poulsen SA
    J Am Chem Soc; 2011 Nov; 133(45):18452-62. PubMed ID: 21958118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.
    Nishimori I; Minakuchi T; Onishi S; Vullo D; Scozzafava A; Supuran CT
    J Med Chem; 2007 Jan; 50(2):381-8. PubMed ID: 17228881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase inhibitors. Design of anticonvulsant sulfonamides incorporating indane moieties.
    Chazalette C; Masereel B; Rolin S; Thiry A; Scozzafava A; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2004 Dec; 14(23):5781-6. PubMed ID: 15501040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates?
    De Simone G; Scozzafava A; Supuran CT
    Chem Biol Drug Des; 2009 Sep; 74(3):317-21. PubMed ID: 19703035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of new carbonic anhydrase inhibitors.
    Xiao Z; Duan R; Cui W; Zhang Y; Zhang S; Chen F; Zhang Y; Liu J; Zhang D; Meng Y; Wang L; Wang H
    Bioorg Med Chem; 2011 May; 19(10):3221-8. PubMed ID: 21524585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro inhibition of α-carbonic anhydrase isozymes by some phenolic compounds.
    Oztürk Sarikaya SB; Topal F; Sentürk M; Gülçin I; Supuran CT
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4259-62. PubMed ID: 21669522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholinesterase and carbonic anhydrase inhibitory properties of novel urea and sulfamide derivatives incorporating dopaminergic 2-aminotetralin scaffolds.
    Özgeriş B; Göksu S; Polat Köse L; Gülçin İ; Salmas RE; Durdagi S; Tümer F; Supuran CT
    Bioorg Med Chem; 2016 May; 24(10):2318-29. PubMed ID: 27068142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonaromatic sulfonamide group as an ideal anchor for potent human carbonic anhydrase inhibitors: role of hydrogen-bonding networks in ligand binding and drug design.
    Abbate F; Supuran CT; Scozzafava A; Orioli P; Stubbs MT; Klebe G
    J Med Chem; 2002 Aug; 45(17):3583-7. PubMed ID: 12166931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-[N-(substituted 4-pyrimidinyl)amino]benzenesulfonamides as inhibitors of carbonic anhydrase isozymes I, II, VII, and XIII.
    Sūdžius J; Baranauskienė L; Golovenko D; Matulienė J; Michailovienė V; Torresan J; Jachno J; Sukackaitė R; Manakova E; Gražulis S; Tumkevičius S; Matulis D
    Bioorg Med Chem; 2010 Nov; 18(21):7413-21. PubMed ID: 20889345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.